Literature DB >> 15102759

In vitro and in vivo characterization of Helicobacter hepaticus cytolethal distending toxin mutants.

Vincent B Young1, Kimberly A Knox, Jason S Pratt, Jennifer S Cortez, Linda S Mansfield, Arlin B Rogers, James G Fox, David B Schauer.   

Abstract

Helicobacter hepaticus expresses a member of the cytolethal distending toxin (CDT) family of bacterial cytotoxins. To investigate the role of CDT in the pathogenesis of H. hepaticus, transposon mutagenesis was used to generate a series of isogenic mutants in and around the cdtABC gene cluster. An H. hepaticus transposon mutant with a disrupted cdtABC coding region no longer produced CDT activity. Conversely, a transposon insertion outside of the cluster did not affect the CDT activity. An examination of these mutants demonstrated that CDT represents the previously described granulating cytotoxin in H. hepaticus. Challenge of C57BL/6 interleukin 10(-/-) mice with isogenic H. hepaticus mutants revealed that CDT expression is not required for colonization of the murine gut. However, a CDT-negative H. hepaticus mutant had a significantly diminished capacity to induce lesions in this murine model of inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15102759      PMCID: PMC387909          DOI: 10.1128/IAI.72.5.2521-2527.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein.

Authors:  M Lara-Tejero; J E Galán
Journal:  Science       Date:  2000-10-13       Impact factor: 47.728

Review 2.  Cytolethal distending toxin: a bacterial toxin which disrupts the eukaryotic cell cycle.

Authors:  V B Young; D B Schauer
Journal:  Chem Res Toxicol       Date:  2000-10       Impact factor: 3.739

3.  Monitoring sentinel mice for Helicobacter hepaticus, H rodentium, and H bilis infection by use of polymerase chain reaction analysis and serologic testing.

Authors:  M T Whary; J H Cline; A E King; K M Hewes; D Chojnacky; A Salvarrey; J G Fox
Journal:  Comp Med       Date:  2000-08       Impact factor: 0.982

4.  Characterisation of cytolethal distending toxin (CDT) mutants of Campylobacter jejuni.

Authors:  D Purdy; C M Buswell; A E Hodgson; K McALPINE; I Henderson; S A Leach
Journal:  J Med Microbiol       Date:  2000-05       Impact factor: 2.472

Review 5.  Emergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases.

Authors:  J V Solnick; D B Schauer
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

6.  Identification of cdtB homologues and cytolethal distending toxin activity in enterohepatic Helicobacter spp.

Authors:  Chih-Ching Chien; Nancy S Taylor; Zhongming Ge; David B Schauer; Vincent B Young; James G Fox
Journal:  J Med Microbiol       Date:  2000-06       Impact factor: 2.472

7.  Cytolethal distending toxin in avian and human isolates of Helicobacter pullorum.

Authors:  V B Young; C C Chien; K A Knox; N S Taylor; D B Schauer; J G Fox
Journal:  J Infect Dis       Date:  2000-07-19       Impact factor: 5.226

8.  Characterization of a Haemophilus ducreyi mutant deficient in expression of cytolethal distending toxin.

Authors:  M K Stevens; J L Latimer; S R Lumbley; C K Ward; L D Cope; T Lagergard; E J Hansen
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

9.  Detection of Helicobacter species in the liver of patients with and without primary liver carcinoma.

Authors:  P Avenaud; A Marais; L Monteiro; B Le Bail; P Bioulac Sage; C Balabaud; F Mégraud
Journal:  Cancer       Date:  2000-10-01       Impact factor: 6.860

10.  Cytolethal distending toxin sequence and activity in the enterohepatic pathogen Helicobacter hepaticus.

Authors:  V B Young; K A Knox; D B Schauer
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

View more
  66 in total

Review 1.  The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models.

Authors:  Sandra Nell; Sebastian Suerbaum; Christine Josenhans
Journal:  Nat Rev Microbiol       Date:  2010-07-12       Impact factor: 60.633

2.  Helicobacter hepaticus hydrogenase mutants are deficient in hydrogen-supported amino acid uptake and in causing liver lesions in A/J mice.

Authors:  Nalini S Mehta; Stephane Benoit; Jagannatha V Mysore; Renato S Sousa; Robert J Maier
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 3.  Oral and intestinal bacterial exotoxins: Potential linked to carcinogenesis.

Authors:  Matthew Silbergleit; Adrian A Vasquez; Carol J Miller; Jun Sun; Ikuko Kato
Journal:  Prog Mol Biol Transl Sci       Date:  2020-04-09       Impact factor: 3.622

Review 4.  Cytolethal distending toxin: a conserved bacterial genotoxin that blocks cell cycle progression, leading to apoptosis of a broad range of mammalian cell lineages.

Authors:  Rasika N Jinadasa; Stephen E Bloom; Robert S Weiss; Gerald E Duhamel
Journal:  Microbiology (Reading)       Date:  2011-05-12       Impact factor: 2.777

5.  Improving the efficiency of transposon mutagenesis in Salmonella enteritidis by overcoming host-restriction barriers.

Authors:  Turki M Dawoud; Tieshan Jiang; Rabindra K Mandal; Steven C Ricke; Young Min Kwon
Journal:  Mol Biotechnol       Date:  2014-11       Impact factor: 2.695

6.  Cytolethal distending toxin-induced release of interleukin-1β by human macrophages is dependent upon activation of glycogen synthase kinase 3β, spleen tyrosine kinase (Syk) and the noncanonical inflammasome.

Authors:  Bruce J Shenker; Lisa M Walker; Zeyed Zekavat; David M Ojcius; Pei-Rong Huang; Kathleen Boesze-Battaglia
Journal:  Cell Microbiol       Date:  2020-03-04       Impact factor: 3.715

7.  Inflammatory bowel disease causes reversible suppression of osteoblast and chondrocyte function in mice.

Authors:  Laura Harris; Patricia Senagore; Vincent B Young; Laura R McCabe
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-03-19       Impact factor: 4.052

8.  Characterization of a Helicobacter hepaticus putA mutant strain in host colonization and oxidative stress.

Authors:  Navasona Krishnan; Alan R Doster; Gerald E Duhamel; Donald F Becker
Journal:  Infect Immun       Date:  2008-05-05       Impact factor: 3.441

9.  Helicobacter typhlonius and Helicobacter rodentium differentially affect the severity of colon inflammation and inflammation-associated neoplasia in IL10-deficient mice.

Authors:  Maciej Chichlowski; Julie M Sharp; Deborah A Vanderford; Matthew H Myles; Laura P Hale
Journal:  Comp Med       Date:  2008-12       Impact factor: 0.982

10.  Genetic background of IL-10(-/-) mice alters host-pathogen interactions with Campylobacter jejuni and influences disease phenotype.

Authors:  L S Mansfield; J S Patterson; B R Fierro; A J Murphy; V A Rathinam; J J Kopper; N I Barbu; T J Onifade; J A Bell
Journal:  Microb Pathog       Date:  2008-06-11       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.